Microbot Medical Inc. logo

Microbot Medical Inc.

MBOT | NASDAQ
Chart Builder DCF Calculator
$1.38
+$0.03 (+2.22%)
At close: Sep 22, 2026, 4:00 PM ET
$1.38
$0 (0.00%)
After-hours: Sep 22, 2026, 7:41 PM ET

Market Data

Market Cap
$61.52M
Enterprise Value
$-4.97M
Beta
1.03
Average Volume
1.12M
Shares Outstanding (Diluted)
67.16M
Shares Change YoY
84.07%
Institutional Ownership
21.20%
Exchange
NASDAQ
ISIN
US59503A2042

Price Performance

Price Change 1M
-10.0%
Price Change 3M
-25.8%
Price Change 6M
-46.6%
Price Change YTD
-36.0%
Price Change 1Y
-59.2%
Price Change 3Y
1.5%
Price Change 5Y
-81.0%
1M CAGR (ann.)
-28.6%
1Y CAGR (ann.)
-56.3%
5Y CAGR (ann.)
-27.8%
All-Time CAGR
-40.9%

Valuation

PE Ratio
-5.19
Forward PE
15.27
PEG Ratio
-0.05
Forward PEG
-0.81
PS Ratio
177.80
Forward PS
9.60
PB Ratio
0.89
P/FCF Ratio
-3.43
P/Adj. FCF Ratio
-3.21
P/OCF Ratio
-5.19
EV/Sales
-14.37
EV/EBIT
0.30
EV/EBITDA
0.31
EV/FCF
0.28
Earnings Yield
-19.3%
FCF Yield
-29.1%
Adj. FCF Yield
-31.1%

Financial Health

Net Cash
$66.49M
Total Debt
$876K
Cash & Short-Term Investments
$67.37M
Total Assets
$73.37M
Current Ratio
18.56
Quick Ratio
17.82
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.05
Debt / FCF
-0.05
OCF / Debt
-20.14
Interest Coverage
0.00
Altman Z-Score
6.54
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
-185.3%
Operating Profit Margin
-5348.8%
EBITDA Margin
-4705.2%
Net Profit Margin
-4722.3%
FCF Margin
-5181.8%
Adj. FCF Margin
-5534.1%
SBC / Revenue
352.3%
SBC Impact (per share)
-6.8%

Returns

Return on Assets
-22.3%
Return on Equity
-21.9%
Return on Invested Capital
-26.5%
Return on Capital Employed
-26.6%
Return on Tangible Assets
-22.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
100.0%
Revenue CAGR 10Y
11.3%
EPS CAGR 3Y
48.0%
EPS CAGR 5Y
39.6%
EPS CAGR 10Y
20.1%
FCF CAGR 3Y
-42.1%
FCF CAGR 5Y
-11.0%
FCF CAGR 10Y
-42.3%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
4
EPS Growth Next 3Y
21.8%
Revenue Growth Next 3Y
418.4%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.08
EPS Growth Est (next Q)
14.3%
Revenue Est (next Q)
$261.33K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$4
Price Target Upside
196.3%

Cash Flow

Operating Cash Flow
$-17.64M
Free Cash Flow
$-17.93M
Adj. Free Cash Flow
$-19.15M
FCF Per Share
-$0.27
OCF Per Share
-$0.26
OCF/S Ratio
-5098.6%

Income Statement

Revenue
$346K
Gross Profit
$-641K
Operating Income
$-18.51M
EBITDA
$-16.28M
Net Income
$-16.34M
EPS (Diluted)
-$0.26
Revenue / Employee
$8.05K
Profit / Employee
$-379.98K
Employees
43

© 2026 bestshares.com. All rights reserved.